Fetomaternal alloimmune thrombocytopenia: The questions that still remain

Janyne Althaus, Karin J. Blakemore

Research output: Contribution to journalReview articlepeer-review

3 Scopus citations


Fetomaternal alloimmune thrombocytopenia (FMAIT) occurs when maternal antibodies are formed to fetal platelet antigens, leading to thrombocytopenia and hemorrhagic complications. The diagnosis is frequently made only after a major hemorrhagic event has occurred during a pregnancy. Identifying patients at risk remains difficult, and the optimal treatment regimen remains to be determined.

Original languageEnglish (US)
Pages (from-to)633-637
Number of pages5
JournalJournal of Maternal-Fetal and Neonatal Medicine
Issue number9
StatePublished - 2007


  • Fetal-maternal thrombocytopenia
  • Intracranial hemorrhage
  • Neonatal alloimmune thrombocytopenia
  • Platelet alloantigens

ASJC Scopus subject areas

  • Pediatrics, Perinatology, and Child Health
  • Obstetrics and Gynecology


Dive into the research topics of 'Fetomaternal alloimmune thrombocytopenia: The questions that still remain'. Together they form a unique fingerprint.

Cite this